Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jun 07, 2022

SELL
$7.81 - $20.45 $168,047 - $440,022
-21,517 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$32.5 - $48.96 $378,430 - $570,090
11,644 Added 117.94%
21,517 $835,000
Q1 2021

May 19, 2021

SELL
$41.61 - $54.3 $1.15 Million - $1.51 Million
-27,745 Reduced 73.75%
9,873 $476,000
Q3 2020

Dec 02, 2020

BUY
$18.49 - $27.24 $695,556 - $1.02 Million
37,618 New
37,618 $1.01 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.48B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.